IRONWOOD PHARMACEUTICALS, INC. Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31)
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) of $6.00 thousand as of 2013-06-30, per its 10-Q filed 2013-08-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 · last filed 2013-08-08
- 2013-06-30: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $6.00K.
- 2013-03-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $3.00K.
- 2012-12-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $1.00K.
- 2012-09-30: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $5.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) |
|---|---|
| 2013-06-30 | $6.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $3.00K 10-Q · filed 2013-04-23 |
| 2012-12-31 | $1.00K 10-Q · filed 2013-08-08 |
| 2012-09-30 | $5.00K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $12.00K 10-Q · filed 2012-08-07 |
| 2012-03-31 | $4.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $10.00K 10-K · filed 2013-02-21 |
| 2010-12-31 | $24.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |